The final AXIS tool following consensus on all components by the Delphi panel
Yes | No | Do not know/comment | ||
---|---|---|---|---|
Introduction | ||||
1 | Were the aims/objectives of the study clear? | |||
Methods | ||||
2 | Was the study design appropriate for the stated aim(s)? | |||
3 | Was the sample size justified? | |||
4 | Was the target/reference population clearly defined? (Is it clear who the research was about?) | |||
5 | Was the sample frame taken from an appropriate population base so that it closely represented the target/reference population under investigation? | |||
6 | Was the selection process likely to select subjects/participants that were representative of the target/reference population under investigation? | |||
7 | Were measures undertaken to address and categorise non-responders? | |||
8 | Were the risk factor and outcome variables measured appropriate to the aims of the study? | |||
9 | Were the risk factor and outcome variables measured correctly using instruments/measurements that had been trialled, piloted or published previously? | |||
10 | Is it clear what was used to determined statistical significance and/or precision estimates? (eg, p values, CIs) | |||
11 | Were the methods (including statistical methods) sufficiently described to enable them to be repeated? | |||
Results | ||||
12 | Were the basic data adequately described? | |||
13 | Does the response rate raise concerns about non-response bias? | |||
14 | If appropriate, was information about non-responders described? | |||
15 | Were the results internally consistent? | |||
16 | Were the results for the analyses described in the methods, presented? | |||
Discussion | ||||
17 | Were the authors’ discussions and conclusions justified by the results? | |||
18 | Were the limitations of the study discussed? | |||
Other | ||||
19 | Were there any funding sources or conflicts of interest that may affect the authors’ interpretation of the results? | |||
20 | Was ethical approval or consent of participants attained? |